{"id":"W3214599575","doi":"10.1182/blood-2021-150496","title":"Risk of Progression in Chronic Phase - Chronic Myeloid Leukemia (CML) Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation (TFR-PRO study): Preliminary Results","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Quebec - Clinical Research Organization in Cancer; Jewish General Hospital","funders":"","keywords":"Discontinuation; Medicine; Internal medicine; Imatinib mesylate; Drug holiday; Myeloid leukemia; Tyrosine-kinase inhibitor; Oncology; Clinical trial; Imatinib; Immunology; Cancer; Human immunodeficiency virus (HIV)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002335615,0.0006759691,0.0006585888,0.0002625285,0.0002818069,0.0007221296,0.0003663759,0.000647801,0.001535893],"category_scores_gemma":[0.002293851,0.0001807587,0.0008399992,0.0003379899,0.0002343936,0.0004019112,0.0004967388,0.0007573146,0.0002994578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004419026,"about_ca_system_score_gemma":0.000662544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001133554,"about_ca_topic_score_gemma":0.001014343,"domain_scores_codex":[0.9991332,0.0005539947,0.00003659243,0.0001189635,0.0000841319,0.00007324453],"domain_scores_gemma":[0.9973412,0.0006338512,0.0008179596,0.000148357,0.0002195445,0.00083901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3225431,0.008667629,0.5798061,0.0004202148,0.001085778,0.0003407949,0.0002542812,0.00131554,0.005003233,0.0001321153,0.002417055,0.07801411],"study_design_scores_gemma":[0.03541026,0.1297361,0.8239357,0.00006900205,0.001451023,0.0008091084,0.0001795225,0.002923537,0.001423259,0.0002018936,0.003814602,0.00004598697],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965979,0.0008565122,0.0002782185,0.0001406318,0.00001341692,0.0002851604,0.001356411,0.00001534504,0.0004563628],"genre_scores_gemma":[0.9939973,0.0004612047,0.0008598826,0.0001707851,0.00009654478,0.0004404751,0.003318918,0.000008117438,0.0006466882],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002335615,"threshold_uncertainty_score":0.01235205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01565194363182705,"score_gpt":0.3103818157024025,"score_spread":0.2947298720705754,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}